Unspecific post-mortem findings despite multiorgan viral spread in COVID-19 patients

BACKGROUND: Post-mortem studies can provide important information for understanding new diseases and small autopsy case series have already reported different findings in COVID-19 patients METHODS: We evaluated whether some specific post-mortem features are observed in these patients and if these changes are related to the presence of the virus in different organs Complete macroscopic and microscopic autopsies were performed on different organs in 17 COVID-19 non-survivors Presence of SARS-CoV-2 was evaluated with immunohistochemistry (IHC) in lung samples and with real-time reverse-transcription polymerase chain reaction (RT-PCR) test in the lung and other organs RESULTS: Pulmonary findings revealed early-stage diffuse alveolar damage (DAD) in 15 out of 17 patients and microthrombi in small lung arteries in 11 patients Late-stage DAD, atypical pneumocytes, and/or acute pneumonia were also observed Four lung infarcts, two acute myocardial infarctions, and one ischemic enteritis were observed There was no evidence of myocarditis, hepatitis, or encephalitis Kidney evaluation revealed the presence of hemosiderin in tubules or pigmented casts in most patients Spongiosis and vascular congestion were the most frequently encountered brain lesions No specific SARS-CoV-2 lesions were observed in any organ IHC revealed positive cells with a heterogeneous distribution in the lungs of 11 of the 17 (65%) patients;RT-PCR yielded a wide distribution of SARS-CoV-2 in different tissues, with 8 patients showing viral presence in all tested organs (i e , lung, heart, spleen, liver, colon, kidney, and brain) CONCLUSIONS: In conclusion, autopsies revealed a great heterogeneity of COVID-19-associated organ injury and the remarkable absence of any specific viral lesions, even when RT-PCR identified the presence of the virus in many organs